These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

419 related items for PubMed ID: 12576871

  • 1. Anoikis induction by quinazoline based alpha 1-adrenoceptor antagonists in prostate cancer cells: antagonistic effect of bcl-2.
    Keledjian K, Kyprianou N.
    J Urol; 2003 Mar; 169(3):1150-6. PubMed ID: 12576871
    [Abstract] [Full Text] [Related]

  • 2. Suppression of human prostate cancer cell growth by alpha1-adrenoceptor antagonists doxazosin and terazosin via induction of apoptosis.
    Kyprianou N, Benning CM.
    Cancer Res; 2000 Aug 15; 60(16):4550-5. PubMed ID: 10969806
    [Abstract] [Full Text] [Related]

  • 3. Quinazoline-derived alpha1-adrenoceptor antagonists induce prostate cancer cell apoptosis via an alpha1-adrenoceptor-independent action.
    Benning CM, Kyprianou N.
    Cancer Res; 2002 Jan 15; 62(2):597-602. PubMed ID: 11809715
    [Abstract] [Full Text] [Related]

  • 4. Apoptotic impact of alpha1-blockers on prostate cancer growth: a myth or an inviting reality?
    Tahmatzopoulos A, Kyprianou N.
    Prostate; 2004 Apr 01; 59(1):91-100. PubMed ID: 14991869
    [Abstract] [Full Text] [Related]

  • 5. Alpha1-adrenoceptor antagonists radiosensitize prostate cancer cells via apoptosis induction.
    Cuellar DC, Rhee J, Kyprianou N.
    Anticancer Res; 2002 Apr 01; 22(3):1673-9. PubMed ID: 12168853
    [Abstract] [Full Text] [Related]

  • 6. Reduction of human prostate tumor vascularity by the alpha1-adrenoceptor antagonist terazosin.
    Keledjian K, Borkowski A, Kim G, Isaacs JT, Jacobs SC, Kyprianou N.
    Prostate; 2001 Jul 01; 48(2):71-8. PubMed ID: 11433417
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Induction of prostate apoptosis by alpha1-adrenoceptor antagonists: mechanistic significance of the quinazoline component.
    Anglin IE, Glassman DT, Kyprianou N.
    Prostate Cancer Prostatic Dis; 2002 Jul 01; 5(2):88-95. PubMed ID: 12496995
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Piperazine-designed alpha 1A/alpha 1D-adrenoceptor blocker KMUP-1 and doxazosin provide down-regulation of androgen receptor and PSA in prostatic LNCaP cells growth and specifically in xenografts.
    Liu CM, Lo YC, Tai MH, Wu BN, Wu WJ, Chou YH, Chai CY, Huang CH, Chen IJ.
    Prostate; 2009 May 01; 69(6):610-23. PubMed ID: 19143029
    [Abstract] [Full Text] [Related]

  • 14. The peroxisome proliferator-activated receptor gamma ligand 15-deoxy-Delta12,14-prostaglandin J2 induces vascular endothelial growth factor in the hormone-independent prostate cancer cell line PC 3 and the urinary bladder carcinoma cell line 5637.
    Haslmayer P, Thalhammer T, Jäger W, Aust S, Steiner G, Ensinger C, Obrist P.
    Int J Oncol; 2002 Oct 01; 21(4):915-20. PubMed ID: 12239635
    [Abstract] [Full Text] [Related]

  • 15. Relative cytotoxic potencies and cell death mechanisms of α1 -adrenoceptor antagonists in prostate cancer cell lines.
    Forbes A, Anoopkumar-Dukie S, Chess-Williams R, McDermott C.
    Prostate; 2016 Jun 01; 76(8):757-66. PubMed ID: 26880388
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.